ARCA BIOPHARMA INC - COM (ABIO)

CUSIP: 00211Y506

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
1,120,678
Share change
-408,892
Total reported value
$2,408,886
Put/Call ratio
84%
Price per share
$2.15
Number of holders
16
Value change
-$1,261,277
Number of buys
7
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 00211Y506?
CUSIP 00211Y506 identifies ABIO - ARCA BIOPHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARCA BIOPHARMA INC - COM (ABIO) as of Q4 2021

As of 31 Dec 2021, ARCA BIOPHARMA INC - COM (ABIO) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,120,678 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, CITADEL ADVISORS LLC, Tekla Capital Management LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and MILLENNIUM MANAGEMENT LLC. This page lists 16 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.